Talk:Toremifene

Latest comment: 11 years ago by 35.11.33.75 in topic Please Keep Article UP TO DATE

SERMs for prostate cancer?

edit

I'm just curious [and one for breast cancer) and that, originally, each trade name was being supported by a different company! InvictaHOG 11:18, 6 December 2005 (UTC)Reply

- I thought abnormal prostate growth and malignancies were pport issue is funny.

PCOS, oligomenorrhoea?

edit

Does toremifene work in PCOS ladies with oligomenorrhoea. JFW | T@lk 12:43, 6 December 2005 (UTC)Reply

Ormeloxifene main article needs editors

edit

I've tried posting in Wikiproject:Clinical medicine, and have found few who know anything about ormeloxifene. Especially needed are chemists, scientists, and doctors who are knowledgable about this SERM. Thank you~ -- Joie de Vivre 14:42, 14 December 2006 (UTC)Reply

Please Keep Article UP TO DATE

edit

It says, "Results of these trials are expected by first quarter of 2008". That time has come and gone. 69.3.145.64 (talk) 04:55, 24 October 2008 (UTC)Reply

Found a later press release (2009 NDA) and there are probably others that we should use. Rod57 (talk) 01:36, 27 March 2010 (UTC)Reply

11/29/2012 This still needs to be updated! — Preceding unsigned comment added by 35.11.33.75 (talk) 03:29, 30 November 2012 (UTC)Reply

Unclear

edit

This article currently comprises of three paragraphs. The last two don't make sense to me. How are they related to the drug? Remember that articles shouldn't only target specialists, so please be clearer. — Preceding unsigned comment added by Wawawemn (talkcontribs) 19:32, 20 August 2011 (UTC)Reply

For example, 2nd paragraph talks about some trials. Are these trials about the drug Toremifene? If so, we should say so there. Also, this paragraph says "results should be out 2008". Where are they? Does the 3rd paragraph talk about the expected results from paragraph 2? If so, the "results should be out 2008" from previous paragraph should be removed. And what does NDA stand for in 3rd paragraph?Wawawemn (talk) 19:42, 20 August 2011 (UTC)Reply